Luchun Li
Chongqing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Gotistobart or docetaxel in metastatic squamous non-small cell lung cancer: stage 1 of the randomized phase 3 PRESERVE-003 trial.
Journal: Nature medicine
Published: January 29, 2026
Primary Pulmonary Lymphoepithelioma-like Carcinoma: A Case Report Utilizing Camrelizumab and Anlotinib for Prolonged Survival.
Journal: Anti-cancer agents in medicinal chemistry
Published: December 26, 2023
S-1 maintenance therapy in advanced gastric cancer without disease progression after first-line chemotherapy: A retrospective analysis.
Journal: Science progress
Published: December 22, 2023
Myocardial extracellular volume derived from contrast-enhanced chest computed tomography in longitudinal evaluation of cardiac toxicity in patients treated with immune checkpoint inhibitors.
Journal: Quantitative imaging in medicine and surgery
Published: June 11, 2023
Fruquintinib in combination with sintilimab or TAS-102 as third-line or above treatment in patients with metastatic colorectal cancer: a real-world study.
Journal: Translational cancer research
Published: May 28, 2023
Efficacy and safety of thrombopoietin receptor agonists in solid tumors with chemotherapy-induced thrombocytopenia: a meta-analysis.
Journal: BMC pharmacology & toxicology
Published: May 24, 2023
Characteristics and Predictors of Venous Thromboembolism Among Lymphoma Patients Undergoing Chemotherapy: A Cohort Study in China.
Journal: Frontiers in pharmacology
Published: March 22, 2022
The effect of icotinib combined with chemotherapy in untreated non-small-cell lung cancer that harbored EGFR-sensitive mutations in a real-life setting: a retrospective analysis.
Journal: OncoTargets and therapy
Published: May 08, 2018
Role of Kruppel-like factor 4 in regulating inhibitor of apoptosis-stimulating protein of p53 in the progression of gastric cancer.
Journal: Oncology letters
Published: June 26, 2017
Inhibition of Hes1 enhances lapatinib sensitivity in gastric cancer sphere-forming cells.
Journal: Oncology letters
Published: November 14, 2015
Showing 1-12 of 12
Last Updated: 09/26/2026